BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Baik SJ, Kim TH, Kim HI, Rhie JY. Myasthenia Crisis Induced by Pegylated-Interferon in Patient With Chronic Hepatitis C: A Case Report. Medicine (Baltimore) 2016;95:e3782. [PMID: 27227948 DOI: 10.1097/MD.0000000000003782] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.2] [Reference Citation Analysis]
Number Citing Articles
1 Huda R. New Approaches to Targeting B Cells for Myasthenia Gravis Therapy. Front Immunol 2020;11:240. [PMID: 32153573 DOI: 10.3389/fimmu.2020.00240] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
2 Krenn M, Grisold A, Wohlfarth P, Rath J, Cetin H, Koneczny I, Zimprich F. Pathomechanisms and Clinical Implications of Myasthenic Syndromes Exacerbated and Induced by Medical Treatments. Front Mol Neurosci 2020;13:156. [PMID: 32922263 DOI: 10.3389/fnmol.2020.00156] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
3 Sheikh S, Alvi U, Soliven B, Rezania K. Drugs That Induce or Cause Deterioration of Myasthenia Gravis: An Update. J Clin Med 2021;10:1537. [PMID: 33917535 DOI: 10.3390/jcm10071537] [Cited by in F6Publishing: 1] [Reference Citation Analysis]